The research suggests that breast cancer metastasis could be reduced by modifying the composition of bile acids.
Morning Overview on MSN
A cancer drug just became the first FDA-cleared treatment for a common breast-cancer subtype
Patients with the most common molecular subtype of advanced breast cancer now have a targeted drug approved specifically for ...
Camrelizumab Plus Famitinib versus Camrelizumab Alone and Investigator's Choice of Chemotherapy in Recurrent or Metastatic Cervical Cancer: A Randomized, Phase II Study POSITIVE is a prospective trial ...
A new study from the University of Virginia Comprehensive Cancer Center has found that an unhealthy gut may do more than ...
Health and Me on MSN
Postpartum breast cancer may be biologically more aggressive; here’s why
A recent study indicates that breast cancer detected after childbirth could be more aggressive as pregnancy and lactation ...
A buildup of bile acids caused by an unhealthy gut can drive breast cancer to other parts of the body, new University of ...
The FDA has approved a new targeted therapy combination for the most common subtype of breast cancer.Gedatolisib (Revtorpyk, Celcuity Inc.) plus fulvestrant, with or without palbociclib (Ibrance, ...
In preclinical studies, researchers at Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine, have tested a new combination therapy for hormone-resistant, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results